Assay note: SSA lot H-2814 reported at 99.2% of label content.
#semaglutide 2025-08-31
- amsterdam_aliquot — my plateau was the scale stopping while appetite stayed suppressed, which is a different problem 17:01
- igf_one_ivy — anyone gone from 5 straight to 7.5 or is that too big a jump 17:56
- a1c_lag — restarted after 21 months off at a low dose and the nausea arrived exactly like the first time 18:26
if youre comparing brand to compounded, dose accuracy in the vial is the variable, not the molecule
the trials titrated on a fixed schedule, most people here dont, worth remembering when comparing
2.4 is the ceiling
five week steps worked better for me than four, purely on how the second week felt
steady state takes weeks
back after 16 months off, do i restart at 0.25 or somewhere higher
STEP 4 had the withdrawal arm, thats the one people quote when they talk about stopping
give it four weeks
anyone compared their 4 vial dosing against the pen increments
quick one went to 2.4 and the extra suppression wasnt worth the GI for me, so i came back down
how long did the first 34kg take for people at the low doses
not the same trial
does the seven day half life mean the last two days are weaker
held at 12 and lost 59lb over 23 months, slower than the trials and fine by me
mine faded too
lost about 17kg on the low doses before i even got to 1, which surprised me
half life is about a week so youre roughly four to five weeks to steady state on any new dose
vial units and pen clicks are different systems, mixing the two is how people end up wrong
does anyone actually run a five week step instead of four
the trials titrated on a fixed schedule, most people here dont, worth remembering when comparing
went 1 to 1.7 too fast and spent two weeks regretting it, dropped back and repeated the step
my plateau was the scale stopping while appetite stayed suppressed, which is a different problem
the plateau hit me at 31 weeks and moved again about a month later without a dose change
i was wrong about the ceiling for a year, i thought 3 existed. it doesnt for the weight indication
does moving my dose day by two days matter with a seven day half life
[edited]seven days ish
thats STEP 1
steady state is the bit people skip, judging a new dose after eight days tells you almost nothing
is there a reason to hold at 1.7 rather than going to 2.4
*Janoshik not the other one
FLOW was the kidney outcomes trial and it gets quoted in here for things it didnt measure
wk 1-4 0.25mg
wk 5-10 0.50mg (held 2 extra weeks)
wk 11-14 1.00mg
wk 15-26 1.70mg (held, long)
wk 27+ 2.40mgi held at 10 for 6 months and it was the best decision i made
SELECT was cardiovascular outcomes in people with overweight and existing disease, not a weight trial
went too fast once
anyone gone from 5 straight to 7.5 or is that too big a jump
wk 1-4 0.25mg
wk 5-10 0.50mg (held 2 extra weeks)
wk 11-14 1.00mg
wk 15-26 1.70mg (held, long)
wk 27+ 2.40mgthe long half life flattens the trough more than people expect, i never felt a day seven dip
what did SELECT actually measure, i see it quoted for everything
restarted after 21 months off at a low dose and the nausea arrived exactly like the first time
plateaus move
same dose day
moving my dose day by a day or two never did anything noticeable for me
SELECT wasnt weight
Inter-lab diff for lot A-2601: 98.1% vs 99%. Within expected range.
i dont think the plateau is a dose problem most of the time, but i cant prove that
vials not pens here
the appetite effect faded for me around 24 months and going up fixed it for a while
compounded and brand felt the same to me at 12, which is one person and nothing more
26 months at 2.4 and the honest summary is diminishing returns after the first half
did anyone titrate slower than four weeks a step and how did that go